-
{{ listItem.name }}快速筛选药品，用摩熵药筛
微信扫一扫-立即使用
-
产品立项评估及管线规划
-
数据定制服务
-
产业/行业调研
-
市场洞察咨询服务
-
报告大厅
已收录 68518 份 -
摩熵说直播
最新改良型新药及创新药立项开发
- GLP-1
ChiCTR2200056193
结束
/
/
/
2022-02-01
/
/
N/A
Hiwa omer: please submit the approval letter of IRB
Sonographic Measurement of Splenic Size and its Correlation with Body Parameters in Kurdish Population
This study aims to establish reference value of splenic dimensions, volume and its correlation to the different body parameters in Kurdish population
连续入组
其它
N/A
N/A
All funding was covered by authors.
/
300
/
2020-08-07
2021-03-05
/
Normal healthy Kurdish adult male and female population in Sulaimani region who had normal complete blood count (CBC)；
登录查看Subjects in this study will fill a short-standardized interview questionnaire to exclude any previous or current conditions that might involve the size of the spleen & exclusion criteria were include: 1. Subjects with age younger than 20 years. 2. Clinical or laboratory evidence of infection or jaundice either at the time of the examination or within at least 6 weeks prior to the examination) 3. History of Rheumatoid disease 4. Anemia or haemoglobinopathies (thalassemia and sickle cell anemia). 5. Subjects with Hx of lymphoproliferative disorders or Myeloproliferative neoplasm 6. Subjects in whom the entire length of the spleen could not be properly documented by US or sonographically detectable focal spleen lesions. 7. History of splenic trauma& or those with partial splenectomy. 8. Liver diseases (cirrhosis or portal hypertension). 9. Gravid women. 10. Non-Kurdish races.；
登录查看medical school, Faculty of Medical Science, University of Sulaimani
/
medical school, Faculty of Medical Science, University of Sulaimani的其他临床试验
伊拉克苏莱曼尼大学的其他临床试验
- COVID-19 associated with pulmonary mucormycosis; a series of four cases
- Hiwa omer: please submit the approval letter of IRB
- Post COVID-19 pulmonary complications: a single center experience
- Large vessel thrombosis in patients with COVID-19
- Severe Reluctant COVID-19 Patients Responding to Convalescent Plasma; A case series
- Combined operation for coronary artery bypass grafting and mitral valve replacement; risk and outcome
- Bilateral Thoracic trauma
最新临床资讯
-
I 期临床 CR 再现！FAST-TIL 彰显体内肿瘤持续杀伤能力！
-
安进跌6%：AMG 133减重二期临床数据不及预期
-
医药笔记2025-06-24
-
HER2 PDL1 三阴性乳腺癌
BioArtMED2025-06-23
-
慢性乙型肝炎
肝脏时间2025-06-23
-
肺动脉高压 宜明凯尔
宜明昂科2025-06-23
-
PCSK9 atherosclerosis
君实医学2025-06-23
-
连花清瘟 流感
精准药物2025-06-23
-
HBV 乙型肝炎 肝硬化
康华股份2025-06-23
-
diabetes
医药观澜2025-06-23
18983288589（微信同号）
18983288589（微信同号）
18908392210（微信同号）
18980413049
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: yl23455永利官网 yl23455永利官网企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网